Nofazinlimab

Nofazinlimab (CS1003) is a humanised IgG4 anti-PD-1 monoclonal antibody. Nofazinlimab can be used for unresectable hepatocellular carcinoma (uHCC) research[1].

Product Specifications

CAS Number

[2377845-98-0]

Product Name Alternative

CS1003

UNSPSC

12352203

Target

PD-1/PD-L1

Type

Inhibitory Antibodies

Related Pathways

Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/nofazinlimab.html

Purity

98.83

Solubility

H2O

Smiles

[Nofazinlimab]

Molecular Weight

(145.08 kDa)

References & Citations

[1]Hong Chen, et al. Isolated adrenocorticotropic hormone deficiency following immune checkpoint inhibitors treatment often occurred in polyglandular endocrinopathies. February 28th, 2023.